Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


High-Ranking FDA Official Steven Niedelman Joins Quintiles Consulting as Executive Vice President

    RESEARCH TRIANGLE PARK, N.C., Aug. 1 /PRNewswire/ -- Steven M.
Niedelman, formerly deputy associate commissioner for Regulatory Operations
for the U.S. Food and Drug Administration, has joined Quintiles Consulting
as executive vice president, Quintiles Transnational Corp. announced today.
    Niedelman, whose 34-year FDA career culminated with responsibility for
approximately one-third of all FDA staff, is responsible for all operations
at Quintiles Consulting, a leading provider of global regulatory,
compliance and validation consulting services to the pharmaceutical,
biologics and medical device industries and product development services to
the medical device industry.
    Niedelman replaces Ron Johnson, who has been appointed to lead The
Lewin Group, a nationally recognized health care and human services
consultancy that is part of the Quintiles family of companies.
    "Steve has played a significant role in shaping and interpreting FDA
regulations over the years and brings a wealth of knowledge and insight to
our clients at Quintiles Consulting," said Tracy Ken Tsuetaki, President of
Quintiles Medical Communications and Consulting. "His management skills and
regulatory knowledge add even greater depth to our team of former FDA staff
and industry experts who provide guidance to the life sciences industry."
    In his most recent role at the FDA, Niedelman served as chief operating
officer of the Office of Regulatory Affairs' (ORA's) headquarters offices.
At ORA, he assured consistent interpretation and implementation of
regulatory policies and oversaw the work of the Office of Regional
Operations, Office of Enforcement and Office of Criminal Investigations, as
well as FDA's 3,400 field staff responsible for investigative and
regulatory laboratory field operations. Among his many duties, he
co-chaired the FDA's Compliance Policy Council and served as the point
person on regulatory and policy issues involving the medical device
industry.
    Before joining ORA, Niedelman was acting director of the Office of
Enforcement, where he had served as deputy director from July 2001 to
September 2002. The Office of Enforcement is responsible for developing and
assuring compliance to agency policies, processing of enforcement actions,
managing recalls, providing information to domestic and foreign governments
about the suitability of a firm's ability to provide compliant products and
developing and implementing the Quality Management System throughout ORA.
    Previously, Niedelman spent 24 years at the Center for Devices and
Radiological Health, where he held management positions throughout the
Office of Compliance. He began his career with the FDA as a consumer safety
officer in 1972 and held positions as an investigator in the FDA's New York
District Office and the White Plains Resident Post.
    Niedelman graduated from the College of Emporia (Kan.) in 1971 with a
bachelor's degree in biology and chemistry. Among the many FDA
acknowledgements he has received throughout his career, Niedelman has twice
earned the FDA Award of Merit and Commendable Service Award. He also
received the first Ronald H. Brown Award from the U.S. Department of
Commerce in recognition of his technical assistance to the international
medical device community.
    About Quintiles Consulting
    Quintiles Consulting provides global strategic regulatory consulting in
the areas of Quality Systems Development and Optimization, FDA Enforcement
Solutions, Validation and Bioresearch Monitoring for the pharmaceutical,
biotechnology and medical device industries. Additionally Quintiles
Consulting offers global strategies and services for medical device
development, including pre-clinical services, clinical trial development
and management, reimbursement and U.S. and European Union submissions.
    About Quintiles Transnational
    Quintiles is the global leader in pharmaceutical services, improving
healthcare worldwide by providing innovative, quality professional
expertise, market intelligence and partnering solutions to meet the dynamic
needs of the pharmaceutical, biotechnology and healthcare industries.
Quintiles has 16,000 specialized employees and offices in 50 countries. For
more information visit the company's Web site at http://www.quintiles.com.


SOURCE Quintiles Transnational Corp.




Back to Topback to top

Related links:
  • http://www.quintiles.com/
    CONTACT:
    Rachael Tarleton Fones, Media Relations of
    Quintiles Transnational Corp., +1-919-998-2136, or
    media.info@quintiles.com